Antibacterial Soaps Reduce Risk Of Foodborne Illness – Industry Study
This article was originally published in The Rose Sheet
Executive Summary
A study funded in part by the Personal Care Products Council found use of antibacterial treatments to reduce concentrations of Shigella bacteria on participants’ hands significantly, leading to reduced levels transferred to melon balls and compelling estimates of reduced illness in eaters. FDA has requested such data as it considers GRASE conditions for antibacterial washes under a proposed rule issued in December 2013 that could require manufacturers to reformulate and relabel products.
You may also be interested in...
Industry Groups Seek Meeting With FDA On Antibacterial Ingredient Studies
The Personal Care Products Council and American Cleaning Institute say industry is undertaking studies on benzethonium and benzalkonium chloride in consumer antimicrobial wash products, but seek input from FDA on study designs and an extended timeframe for their completion. The agency’s commitment to publish a final monograph regarding triclosan use by September 2016, per a late 2013 consent decree, should not have bearing on the GRASE status of other antibacterial ingredients or industry’s efforts to provide data supporting their safe and efficacious use, the groups say.
Industry Cost Estimates For Proposed Antibacterials Rule Dwarf FDA’s
In comments to FDA, the Personal Care Products Council and American Cleaning Institute challenge agency cost projections and question the need for clinical study data to back the efficacy of antibacterial hand-wash products, as called for in a proposed rule issued by the agency in December 2013. Groups say manufacturers require guidance and request an extension of the deadline for data submissions, current set for December 2014.
Minnesota First State To Ban Triclosan In Personal Cleansing Products
Minnesota Governor Mark Dayton has signed a bill that will ban personal cleansing products that contain triclosan from sale in the state, beginning Jan. 1, 2017. The legislation exempts products approved for consumer use by FDA, which currently is reevaluating the safety and efficacy of ingredients in antibacterial soaps used by consumers.